A Prospective Study of Three Post-Remission Therapies in Adult Acute Nonlymphocytic Leukemia: Allogeneic Transplantation vs. Autologous Transplantation vs. Consolidation Chemotherapy

Association between body mass index and cancer survival in a pooled analysis of 22 clinical trials

H Greenlee;J Unger;M Leblanc;S Ramsey;D Hershman Cancer Epidemiology Biomarkers & Prevention 2017 Jan;26(1):21-29; 2016 Dec 16. [Epub ahead of print]

PMid: PMID27986655 | PMC number: PMC5370550

Association between BMI at treatment initiation and cancer survival across multiple SWOG trials

H Greenlee;J Unger;M Leblanc;D Hershman AACR Research International Conference on Frontiers on Cancer Research Prevention (Sept 28-Oct 1, 2014, New Orleans, LA; poster

The effect of complete remission (CR) and CR with incomplete platelet recovery (CRp) on outcome in acute myeloid leukemia: a combined eastern cooperative oncology group (ECOG), Southwest Oncology Group (SWOG), and M.D. Anderson Cancer Center study

Journal of Clinical Oncology 28(10):1766-1771;

Glutathione S-transferase theta 1 gene deletion and risk of acute myeloid leukemia

C Crump;C Chen;FR Appel baum;KJ Kopecky;SM Schwartz;CL Willman;ML Slovak;NS Weiss Cancer Epidemiology Biomarkers & Prevention 9:457-460

Estrogen receptor methylation is a favorable prognostic factor in AML.

JJ Issa;KJ Kopecky;F Appelbaum;C Willman;SB Baylin American Society of Clinical Oncology 15:357(#1048)

Effect of aggressive daunomycin therapy on survival in acute promyelocytic leukemia.

D Head;KJ Kopecky;J Weick;JC Files;D Ryan;K Foucar;M Montiel;J Bickers;A Fishleder;M Miller;C Spier;C Hanson;M Bitter;R Braziel;G Mills;J Welborn;W Williams;J Hewlett;C Willman;FR Appelbaum Blood 86(5):1717-1728

Treatment outcome with chemotherapy in acute promyelocytic leukemia: the Southwest Oncology Group (SWOG) experience.

DR Head;KJ Kopecky;C Willman;FR Appelbaum Leukemia 8(Suppl.2):S38-S41

Reply to comments by Fenaux and Warrell.

DR Head;KJ Kopecky;C Willman;FR Appelbaum Leukemia 8(Suppl.2):S62